ProPhase Labs, Inc.
PRPH
$0.416
$0.00852.09%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.15M | 2.47M | 3.63M | 3.50M | 8.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.15M | 2.47M | 3.63M | 3.50M | 8.37M |
| Cost of Revenue | 3.31M | 2.95M | 4.07M | 6.56M | 6.04M |
| Gross Profit | -165.00K | -476.00K | -433.00K | -3.06M | 2.33M |
| SG&A Expenses | 7.65M | 7.21M | 7.59M | 8.02M | 8.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.08M | 10.30M | 11.93M | 14.85M | 14.84M |
| Operating Income | -7.94M | -7.83M | -8.30M | -11.35M | -6.48M |
| Income Before Tax | -9.10M | -8.44M | -8.83M | -11.67M | -6.79M |
| Income Tax Expenses | -2.51M | -2.29M | -2.57M | -2.91M | -1.64M |
| Earnings from Continuing Operations | -6.59M | -6.15M | -6.27M | -8.75M | -5.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.59M | -6.15M | -6.27M | -8.75M | -5.14M |
| EBIT | -7.94M | -7.83M | -8.30M | -11.35M | -6.48M |
| EBITDA | -5.55M | -6.21M | -6.61M | -9.51M | -4.68M |
| EPS Basic | -0.35 | -0.33 | -0.35 | -0.48 | -0.30 |
| Normalized Basic EPS | -0.30 | -0.28 | -0.31 | -0.40 | -0.25 |
| EPS Diluted | -0.35 | -0.33 | -0.35 | -0.49 | -0.30 |
| Normalized Diluted EPS | -0.30 | -0.28 | -0.31 | -0.40 | -0.25 |
| Average Basic Shares Outstanding | 19.08M | 18.89M | 18.05M | 18.06M | 17.18M |
| Average Diluted Shares Outstanding | 19.08M | 18.89M | 18.05M | 18.06M | 17.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
